PEAK Scientific and Bioz Extend Partnership, Delivering Data-Driven Validation to Scientists
Bioz Prime Badges, the advanced digital marketing widgets that PEAK Scientific is leveraging, offer an interactive way for scientists to see how PEAK Scientific's gas generators are cited in published research. These AI-powered badges showcase real-world applications, allowing researchers to explore relevant studies, access full citations, and make data-driven purchasing decisions with confidence.
Bruce Peat, Head of Marketing at PEAK Scientific, highlighted the value of this ongoing collaboration: 'We are pleased to continue our partnership with Bioz, as their AI-powered validation tools provide our customers with valuable insights into the real-world use of our products. The ability to showcase peer-reviewed citations directly on our website enhances researcher confidence and engagement.'
Beyond providing validation, PEAK Scientific has experienced strong engagement with Bioz Prime Badges, demonstrating the impact of transparent, citation-backed product insights. Their decision to renew this partnership underscores their dedication to supporting scientists with evidence-based tools that optimize purchasing decision-making.
'PEAK Scientific's continued collaboration with Bioz is a testament to the power of AI-driven citation validation. By leveraging Bioz Prime Badges, they are not only increasing engagement and visibility but also strengthening trust among researchers who rely on peer-reviewed data,' said Dr. Karin Lachmi, Chief Revenue Officer and Co-Founder of Bioz.
Through this renewed partnership, PEAK Scientific and Bioz remain committed to empowering the scientific community with data-driven insights that streamline research and procurement.
About Bioz
Bioz is the world's most advanced AI search engine for scientific research, offering evidence-based product ratings and recommendations to guide scientists toward the most validated products for their discoveries. Bioz's solutions for suppliers include Bioz Badges and Content Hubs, web-based widgets that enhance user engagement and increase sales conversion.
About PEAK Scientific
Peak Scientific is a world leader in laboratory gas generation, specializing in the design, manufacture, and servicing of high-performance gas generators for analytical laboratories. With over 25 years of innovation, Peak Scientific provides reliable, cost-effective, and energy-efficient solutions for gas chromatography (GC), liquid chromatography-mass spectrometry (LC-MS), and other laboratory applications.
Helpful Links
For more information on Bioz solutions for suppliers, please reach out to [email protected].
Contact Information Daniel Levitt CEO
SOURCE: Bioz, Inc.
press release
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 days ago
- Yahoo
Piper Sandler Upgrades HubSpot (HUBS) After Better-Than-Feared Q2 Performance
HubSpot, Inc. (NYSE:HUBS) is one of the best falling stocks to buy now. On August 7, Piper Sandler upgraded HubSpot shares from 'Neutral' to 'Overweight' and raised its price target from $645 to $675. Piper Sandler cited HubSpot's 'better-than-feared' second-quarter performance. HubSpot reported Q2 2025 financial results on August 6 and posted $760.9 million in total revenue, up 19% y-o-y. Income from the Professional services & other segment led the charge, surging 21% y-o-y to $16.3 million, while Subscription revenue reached $744.5 million, up 19%. The total revenue beat Piper Sandler's projections by $22 million, although $5 million of the beat was attributed to foreign exchange. Piper Sandler's analysts see 'early signs of a product-led turnaround', which catalyzed the rating upgrade. The firm also pointed to a rebound in HubSpot's core Americas market, with revenue growth increasing to 18.4% from 17.1% in the prior quarter. The company added 9,724 new customers, exceeding its guidance. It showed improvements in customer retention and multi-product adoption, with '42% of annual recurring revenue now coming from customers using three or more products.' HubSpot, Inc. (NYSE:HUBS) is an American software company. It provides a cloud-based customer relationship management (CRM) platform that includes tools for marketing automation, sales enablement, customer service, and content management. The company serves over 258,000 customers globally, primarily small and mid-sized businesses, through products such as Marketing Hub, Sales Hub, and Service Hub. While we acknowledge the potential of HUBS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 12 Best Copper Stocks to Buy According to Hedge Funds and 10 Best EV Penny Stocks to Buy According to Hedge Funds. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Wall Street Journal
4 days ago
- Wall Street Journal
Apollo and Motive Partners Set Up New Private-Markets Servicer
Asset managers Apollo Global Management and Motive Partners are backing the formation of a new private-markets services provider. The new company, set up by combining fund administrator Alchelyst and Apollo spinout Lyra Client Solutions, will offer private-markets fund administration services for institutional investors and wealth advisers. The business is expected to help fund sponsors meet growing investor demands for swift, frictionless and transparent services.
Yahoo
06-08-2025
- Yahoo
HubSpot (NYSE:HUBS) Beats Q2 Sales Targets, Full-Year Outlook Slightly Exceeds Expectations
Sales and marketing software maker HubSpot (NYSE:HUBS) announced better-than-expected revenue in Q2 CY2025, with sales up 19.4% year on year to $760.9 million. Guidance for next quarter's revenue was better than expected at $786 million at the midpoint, 1.4% above analysts' estimates. Its non-GAAP profit of $2.19 per share was 3.1% above analysts' consensus estimates. Is now the time to buy HubSpot? Find out in our full research report. HubSpot (HUBS) Q2 CY2025 Highlights: Revenue: $760.9 million vs analyst estimates of $739.3 million (19.4% year-on-year growth, 2.9% beat) Adjusted EPS: $2.19 vs analyst estimates of $2.12 (3.1% beat) Adjusted Operating Income: $129.1 million vs analyst estimates of $124.9 million (17% margin, 3.4% beat) The company lifted its revenue guidance for the full year to $3.08 billion at the midpoint from $3.04 billion, a 1.4% increase Management raised its full-year Adjusted EPS guidance to $9.50 at the midpoint, a 1.8% increase Operating Margin: -3.2%, in line with the same quarter last year Free Cash Flow Margin: 15.3%, down from 16.5% in the previous quarter Customers: 267,982, up from 258,258 in the previous quarter Billings: $785.3 million at quarter end, up 21.2% year on year Market Capitalization: $25.96 billion 'Q2 was another solid quarter of continued revenue growth and customer expansion,' said Yamini Rangan, Chief Executive Officer at HubSpot. Company Overview Started in 2006 by two MIT grad students, HubSpot (NYSE:HUBS) is a software-as-a-service platform that helps small and medium-sized businesses market themselves, sell, and get found on the internet. Revenue Growth Reviewing a company's long-term sales performance reveals insights into its quality. Any business can experience short-term success, but top-performing ones enjoy sustained growth for years. Over the last three years, HubSpot grew its sales at a decent 23.1% compounded annual growth rate. Its growth was slightly above the average software company and shows its offerings resonate with customers. This quarter, HubSpot reported year-on-year revenue growth of 19.4%, and its $760.9 million of revenue exceeded Wall Street's estimates by 2.9%. Company management is currently guiding for a 17.4% year-on-year increase in sales next quarter. Looking further ahead, sell-side analysts expect revenue to grow 14.9% over the next 12 months, a deceleration versus the last three years. Despite the slowdown, this projection is healthy and implies the market is baking in success for its products and services. Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) stock benefiting from the rise of AI. Click here to access our free report one of our favorites growth stories. Billings Billings is a non-GAAP metric that is often called 'cash revenue' because it shows how much money the company has collected from customers in a certain period. This is different from revenue, which must be recognized in pieces over the length of a contract. HubSpot's billings punched in at $785.3 million in Q2, and over the last four quarters, its growth was impressive as it averaged 20.1% year-on-year increases. This performance aligned with its total sales growth, indicating robust customer demand. The high level of cash collected from customers also enhances liquidity and provides a solid foundation for future investments and growth. Customer Base HubSpot reported 267,982 customers at the end of the quarter, a sequential increase of 9,724. That's roughly in line with what we've observed over the last year, confirming that the company is maintaining its sales momentum. Key Takeaways from HubSpot's Q2 Results We enjoyed seeing HubSpot beat analysts' billings expectations this quarter. We were also glad its full-year EPS guidance slightly exceeded Wall Street's estimates. Overall, we think this was a decent quarter with some key metrics above expectations. The stock traded up 4.4% to $512 immediately following the results. HubSpot put up rock-solid earnings, but one quarter doesn't necessarily make the stock a buy. Let's see if this is a good investment. We think that the latest quarter is just one piece of the longer-term business quality puzzle. Quality, when combined with valuation, can help determine if the stock is a buy. We cover that in our actionable full research report which you can read here, it's free. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
